Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Shares Outstanding (Diluted Average) (2017 - 2025)

Historic Shares Outstanding (Diluted Average) for Champions Oncology (CSBR) over the last 13 years, with Q4 2025 value amounting to $14.5 million.

  • Champions Oncology's Shares Outstanding (Diluted Average) rose 305.19% to $14.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $14.5 million, marking a year-over-year increase of 305.19%. This contributed to the annual value of $14.3 million for FY2025, which is 530.85% up from last year.
  • According to the latest figures from Q4 2025, Champions Oncology's Shares Outstanding (Diluted Average) is $14.5 million, which was up 305.19% from $13.8 million recorded in Q3 2025.
  • Champions Oncology's 5-year Shares Outstanding (Diluted Average) high stood at $14.6 million for Q2 2021, and its period low was $13.4 million during Q3 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $13.9 million (2024), whereas its average is $13.9 million.
  • In the last 5 years, Champions Oncology's Shares Outstanding (Diluted Average) soared by 2305.15% in 2021 and then crashed by 701.41% in 2022.
  • Over the past 5 years, Champions Oncology's Shares Outstanding (Diluted Average) (Quarter) stood at $14.5 million in 2021, then fell by 7.01% to $13.5 million in 2022, then grew by 0.01% to $13.5 million in 2023, then grew by 3.7% to $14.0 million in 2024, then rose by 3.05% to $14.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $14.5 million in Q4 2025, compared to $13.8 million in Q3 2025 and $14.3 million in Q2 2025.